Adam Feuerstein tweeted...
View Adam Feuerstein's timeline and complete journalist profile →My second story on #ASCO12 data, focused on $PFE $GSK $JNJ (Zytiga). The latter impressive, bodes well for $MDVN http://t.co/hjlmWxAE
— Adam Feuerstein (@) May 16, 2012
Sign up to discover more journalists who cover and more.
Create An AccountShare This Profile
